Published in Leuk Res on February 22, 2007
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Treating rheumatic patients with a malignancy. Arthritis Res Ther (2011) 1.03
Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant (2013) 0.92
Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways. PLoS One (2013) 0.85
Transcriptomic changes induced by mycophenolic acid in gastric cancer cells. Am J Transl Res (2013) 0.81
Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid. Int J Clin Exp Pathol (2013) 0.79
Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts. BMC Cancer (2016) 0.79
In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha. Br J Pharmacol (2010) 0.77
Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol (2007) 1.99
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res (2005) 1.65
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci (2006) 1.59
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol (2002) 1.35
Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol (2002) 1.23
2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. Hepatology (2004) 1.17
Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. Am J Pathol (2007) 1.15
Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver. Hepatology (2005) 1.12
ABCC6 is a basolateral plasma membrane protein. Circ Res (2013) 1.08
Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathol Oncol Res (2010) 1.08
A novel concept of glomeruloid body formation in experimental cerebral metastases. J Neuropathol Exp Neurol (2003) 1.02
Integrating molecular diagnostics into anticancer drug discovery. Nat Rev Drug Discov (2010) 1.02
Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab Invest (2010) 1.02
ROR1 expression is not a unique marker of CLL. Hematol Oncol (2011) 1.01
Ticks and the city: ectoparasites of the Northern white-breasted hedgehog (Erinaceus roumanicus) in an urban park. Ticks Tick Borne Dis (2011) 1.01
Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol (2006) 1.00
Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Res (2005) 0.99
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria. Pathol Oncol Res (2006) 0.95
Malignancies after renal transplantation during 33 years at a single center. Pathol Oncol Res (2007) 0.94
Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer. Int J Cancer (2005) 0.93
Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis. Pathol Oncol Res (2003) 0.93
Comparative study on cardiotoxic effect of Tinuvin 770: a light stabilizer of medical plastics in rat model. Toxicol Sci (2003) 0.93
Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL). PLoS One (2013) 0.91
Malignant peripheral nerve sheath tumor of the liver: a case report. Pathol Oncol Res (2008) 0.90
Candidatus Neoehrlichia mikurensis and Anaplasma phagocytophilum in urban hedgehogs. Emerg Infect Dis (2014) 0.90
Development of arterial blood supply in experimental liver metastases. Am J Pathol (2009) 0.89
Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study. Mod Pathol (2012) 0.88
Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. Diagn Pathol (2012) 0.88
Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Curr Cancer Drug Targets (2010) 0.88
Lack of angiogenesis in experimental brain metastases. J Neuropathol Exp Neurol (2011) 0.88
Structural analysis of oval-cell-mediated liver regeneration in rats. Hepatology (2012) 0.87
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study. BMC Cancer (2013) 0.86
Architectural changes during regenerative and ontogenic liver growth in the rat. Liver Transpl (2009) 0.86
The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract (2005) 0.86
Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. PLoS One (2012) 0.85
Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. World J Gastroenterol (2005) 0.85
Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability. Mod Pathol (2010) 0.85
Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Res (2004) 0.84
Immunohistochemical classification of ductular reactions in human liver. Histopathology (2010) 0.83
Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes. Histochem Cell Biol (2008) 0.83
Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells. Anticancer Res (2005) 0.83
In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer (2004) 0.83
Knobbed acrosome defect is associated with a region containing the genes STK17b and HECW2 on porcine chromosome 15. BMC Genomics (2010) 0.82
Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes Chromosomes Cancer (2009) 0.82
Smad signal and TGFbeta induced apoptosis in human lymphoma cells. Cytokine (2005) 0.82
Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res (2004) 0.82
mTOR pathway as a potential target in a subset of human medulloblastoma. Pathol Oncol Res (2014) 0.82
Adhesion dynamics and cytoskeletal structure of gliding human fibrosarcoma cells: a hypothetical model of cell migration. Exp Cell Res (2003) 0.81
Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma. Haematologica (2004) 0.81
DLK is a novel immunohistochemical marker for adrenal gland tumors. Virchows Arch (2009) 0.81
Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus. Pathol Oncol Res (2008) 0.80
Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Pathol Oncol Res (2011) 0.80
The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs. Diagn Mol Pathol (2011) 0.80
Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors. Assay Drug Dev Technol (2007) 0.80
Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas. Virchows Arch (2008) 0.80
Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells. Exp Cell Res (2007) 0.80
The presence of human papillomavirus 16 in neural structures and vascular endothelial cells. Virology (2006) 0.80
Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma. Melanoma Res (2004) 0.80
Detection of Drug-induced Apoptosis by Flow Cytometry after Alkaline Extraction of Ethanol Fixed Cells. Pathol Oncol Res (1996) 0.80
Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma. Leuk Lymphoma (2004) 0.79
TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8. Anticancer Res (2003) 0.79
Effect of Fraxiparine and heparin on experimental tumor metastasis in mice. Anticancer Res (2005) 0.79
The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone. Virchows Arch (2013) 0.79
The use of autologous rectus facia sheath for replacement of inferior caval vein defect in orthotopic liver transplantation. Transpl Int (2005) 0.79
Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol (2005) 0.79
Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia. Pathol Oncol Res (2014) 0.78
Telomere length analysis on cord blood cells by the flow-FISH method. Haematologia (Budap) (2002) 0.78
Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt. Pathol Oncol Res (2014) 0.78
The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematol Oncol (2008) 0.78
Tissue-specific homing of immune cells in malignant skin tumors. Pathol Oncol Res (2012) 0.78
[Surgical aspects of pediatric liver transplantation. Living donor liver transplant program in Hungary]. Orv Hetil (2008) 0.78
Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. Pathol Oncol Res (2009) 0.78
[Comparison of the results of conventional, crossclamp and piggyback technique in liver transplantation]. Magy Seb (2005) 0.77
Expansion of hepatic stem cell compartment boosts liver regeneration. Stem Cells Dev (2013) 0.77
[Mevastatin induced apoptosis in U266 human myeloma cell line]. Magy Onkol (2005) 0.77
[Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magy Onkol (2006) 0.77
Vector-borne agents detected in fleas of the northern white-breasted hedgehog. Vector Borne Zoonotic Dis (2013) 0.77
Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis. Pathol Oncol Res (1997) 0.77